Company Filing History:
Years Active: 2012
Title: Ejvind Jensen: Innovator in Pharmaceutical Compositions
Introduction
Ejvind Jensen is a notable inventor based in Birkerød, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for the treatment of diabetes and bulimia. His work is characterized by a focus on innovative solutions that address critical health issues.
Latest Patents
Ejvind Jensen holds a patent for "Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia." This patent highlights his expertise in creating effective pharmaceutical compositions that combine meal-related insulin peptides with insulinotropic peptides.
Career Highlights
Jensen is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His role at Novo Nordisk has allowed him to further his research and development efforts in the pharmaceutical industry.
Collaborations
Ejvind Jensen has collaborated with esteemed colleagues such as Liselotte Bjerre Knudsen and Kristian Tage Hansen. These partnerships have contributed to the advancement of his research and the successful development of innovative pharmaceutical solutions.
Conclusion
Ejvind Jensen's work in pharmaceutical compositions exemplifies the impact of innovation in healthcare. His contributions are vital in the ongoing fight against diabetes and bulimia, showcasing the importance of research and collaboration in the field.